For the GDM group, maternal metabolic and hormonal state remained altered (e.g. hyperinsulinemia and hyperglycaemia) at the end of pregnancy as compared to controls (e.g. C-peptide, insulin and glucose plasma levels). This evidence concerns the gene INS and gestational diabetes.